AMH and ovarian dysfunction: When comparing women with and without BRCA pathogenic variants undergoing fertility preservation, all women with a history of non-breast cancer and/or ovarian surgery, gonadotoxic therapy before presentation, ovarian dysfunction (e.g. PCOS), were excluded in order to avoid interference with AMH level.